FILE PHOTO: Monsanto’s research farm is pictured near Carman, Manitoba, Canada August 3, 2017. REUTERS/Zachary Prong/File Photo (This Nov 9 story corrects paragraph 11 to remove phrase at end to show Spiegelhalter did NOT say the possible association with AML ... More »
Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist to treat patients with BRAF V600-positive stage III melanoma following surgery. More »
A California judge on Friday threw out a $417 million verdict against Johnson & Johnson (JNJ.N) in a lawsuit by a woman who claimed she developed ovarian cancer after using its talc-based products like Johnson's Baby Powder for feminine hygiene. More »
An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines. More »
Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. More »
The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. More »
Up to 6.6 million early deaths in America might be averted over 10 years if smokers switched to e-cigarettes, and the nicotine delivery devices should be adopted as part of an "endgame for cigarette smoking", researchers said on Monday. More »
Emmy-winning comedic actress Julia Louis-Dreyfus said on Thursday that she was battling breast cancer and highlighted the case for universal healthcare. More »
The World Health Organization told governments on Thursday not to get involved in a foundation funded by tobacco firm Philip Morris International to look at ways of reducing the harm from smoking. More »
The U.S. Food and Drug Administration said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed following prior treatment. More »
Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche with slipping sales failed in a separate study with a similar patient group. More »
Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients who have had surgery to remove disease, researchers reported on Monday. More »
A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients, data from a closely watched clinical trial showed on Sunday. More »
Eli Lilly staked its claim for a slice of sales in a new class of breast cancer drugs on Sunday as clinical data showed adding its medicine abemaciclib to standard therapy reduced the risk of disease progression by 46 percent. More »
A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping to predict which patients may respond best to some immunotherapies. More »
Giving Merck & Co's immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clinical trial. More »
The alcohol industry uses denial, distortion and distraction to mislead people about the risks of developing cancer from drinking, often employing similar tactics to those of the tobacco industry, a study said on Thursday. More »
French cell therapy specialist Cellectis, which is developing a gene-modified cancer treatment similar to Novartis's recently approved Kymriah, has been forced to suspend testing following a patient death. More »
By Andrew M. Seaman(Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers report More »
A 38-year-old Orlando woman who pretended to have terminal cancer and accepted donations when she lived in New York's Westchester County several years ago was arrested on Friday and charged with fraud, U.S. prosecutors said. More »
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014. AstraZeneca said on Tuesday that U.S. regulators had awarded its blood cancer drug acalabrutinib “breakthrough” status for the treatment of patients with... More »
By Ronnie Cohen(Reuters Health) – An initiative to enroll dying veterans in hospice care appears to be working, and its success may offer clues for h More »
By Carolyn Crist(Reuters Health) – Nearly 37 percent of Americans have advanced directives for end-of-life care if they become seriously ill or unabl More »
By Andrew M. Seaman(Reuters Health) – People who want access to the best cancer treatment centers in the U.S. may want to avoid health insurance pla More »
Cancer deaths in America’s rural areas are not falling as much as they are in urban areas even though the total deaths from the disease are dropping across the country, a U.S health agency report showed, emphasizing the gap in access to healthcare. More »
British liquid biopsy company Angle said its Parsortix blood test had beaten current methods in identifying ovarian cancer, a breakthough that could help women receive the best possible outcome from surgery. More »
By Carolyn Crist(Reuters Health) – Cancer patients receiving chemotherapy should have all their medications and herbal supplements reviewed by a phar More »
FILE PHOTO: The logo of AstraZeneca is seen on a medication package in a pharmacy in London, Britain, April 28, 2014. REUTERS/Stefan Wermuth/File Photo Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca’s drug Ly... More »
By Shereen Lehman(Reuters Health) – – Death rates from liver cancer in the U.S. have doubled since the 1980s and continue to rise, largely due to ris More »
By Lisa Rapaport(Reuters Health) – After an abnormal mammogram, Asian women in the U.S. are less likely than white women to get follow-up tests to de More »
By Lisa Rapaport(Reuters Health) – A government-backed research collaboration program started in the 1950s has added about 3.34 million years of life More »
Kite Pharma Inc said on Monday it planned to launch in the fourth quarter of this year a Phase 2 trial of its experimental T-cell therapy in leukemia patients, possibly at a lower dose than is currently being tested. More »
By Lisa Rapaport(Reuters Health) – – A new type of “heat-not-burn” cigarette releases some of the same cancer-causing chemicals found in traditional More »
By Carolyn CristNon-drug approaches that work best at relieving cancer-related fatigue may differ during and after cancer treatment, according to an More »
FILE PHOTO – A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo The number of new drugs approved for sale in United States and Europe has bounced back this year, sugge... More »
Puma Biotechnology Inc’s experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the U.S. Food and Drug Administration concluded on Wednesday. More »
FILE PHOTO – Genetically modified male Aedes aegypti mosquitoes are pictured at Oxitec factory in Piracicaba, Brazil, October 26, 2016. REUTERS/Paulo Whitaker Scientists in Britain plan to harness the Zika virus to try to kill brain tumor cells in experiments ... More »
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck’s pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky Merck & ... More »
The inside of a prototype of a drift tube of the new linear accelerator Linac 4, the newest accelerator acquisition since the Large Hadron Collider (LHC), which is due to feed the CERN accelerator complex with particle beams of higher energy, is pictured durin... More »
The introduction of plain packaging for tobacco cigarettes sold in Britain from next month could cut the number of smokers in the country by another 300,000 within a year, researchers said on Thursday. More »
FILE PHOTO: Tesla Chief Executive, Elon Musk enters the lobby of Trump Tower in Manhattan, New York, U.S., January 6, 2017. REUTERS/Shannon Stapleton/File Photo Tesla Inc (TSLA.O) founder and Chief Executive Elon Musk said his latest company Neuralink Corp is ... More »
FILE PHOTO – Commuters cycle past a bus queue outside Waterloo Station in London, Britain August 6, 2015. REUTERS/Dylan Martinez/File Photo People who cycle to work have a substantially lower risk of developing cancer or heart disease or dying prematurely, and... More »
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. Shire said on July 18 that it had accepted an offer of 32 billion pounds ($54.7 billion) from AbbVie. REUTERS/Brendan McDermid AbbVie I... More »
By Will Boggs MD(Reuters Health) – If you have early-stage breast cancer and have undergone genetic testing, the odds are high that the results were More »
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland, January 25, 2017. REUTERS/Arnd Wiegmann/File Photo Novartis AG on Wednesday said the U.S. Food and Drug Administration (FDA) has agreed to accelerate its rev... More »
U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. More »
About two thirds of cancers are caused by random typos in DNA that occur as normal cells make copies of themselves, a finding that helps explain why healthy individuals who do everything they can to avoid cancer are still stricken with the disease, U.S. resear... More »
By Lisa Rapaport(Reuters Health) – Comfort care for advanced cancer patients is associated with fewer repeat hospitalizations and more hospice referr More »
A customer smokes a cigarette in a cafe in Prague, Czech Republic, May 25, 2016. REUTERS/David W Cerny/File Photo A global tobacco treaty put in place in 2005 has helped reduce smoking rates by 2.5 percent worldwide in 10 years, researchers said on Tuesday, bu... More »
Monsanto logo is displayed on a screen where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S. on May 9, 2016. REUTERS/Brendan McDermid/File Photo Employees of Monsanto Co ghostwrote scientific reports that U.S. regu... More »
Merck & Co Inc said on Tuesday it had got a nod from the U.S. Food and Drug Administration for its already-approved immunotherapy drug Keytruda as a treatment for a type of blood cancer. More »
A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble AstraZeneca’s ovarian cancer drug Lynparza slashed the risk of disease progression in a closely watched clinical trial, boosting its profile against rivals ... More »
Jill Biden (L) introduces her husband, former U.S. Vice-President Joe Biden, to speak about the Biden Cancer Initiative at the South by Southwest (SXSW) Music Film Interactive Festival 2017 in Austin, Texas, U.S., March 12, 2017. REUTERS/Brian Snyder Former De... More »
Children look for plastic bottles at the polluted Bagmati River in Kathmandu March 22, 2013. REUTERS/Navesh Chitrakar A quarter of all global deaths of children under five are due to unhealthy or polluted environments including dirty water and air, second-hand... More »
By Andrew M. Seaman(Reuters Health) – – Obese people in the U.S. may not receive the same kind of care at the end of their lives as people who are t More »
A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. REUTERS/Shannon Stapleton/Illustration/File Photo Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in i... More »
By Lisa Rapaport(Reuters Health) – – Internet-based psychotherapy focused on changing behavior may be tied to improved body image and sexual function More »
By Lisa Rapaport(Reuters Health) – Skin cancers caused by indoor tanning are responsible for $343 million a year in direct medical costs for U.S. pat More »
By Ronnie Cohen(Reuters Health) – Poor women undergoing breast cancer treatment are four times more likely to lose their jobs than their high-income More »
By Madeline Kennedy(Reuters Health) – As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with pa More »
By Andrew M. Seaman(Reuters Health) – After prostate removal for cancer, men sometimes complain to their doctors that their penis shrank, but a new More »
FILE PHOTO: Packets of Herceptin sit on a pharmacy shelf in London, Britiain, June 9, 2006. REUTERS/Luke MacGregor/File Photo Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche’s blood cancer drug Ri... More »
By Lisa Rapaport(Reuters Health) – Doctors may diagnose breast cancer later and be less likely to offer needed radiation for Hispanic immigrants than More »
By Lisa Rapaport(Reuters Health) – Women whose breasts are composed mainly of dense glandular tissue rather than fat may have higher odds of developi More »
By Andrew M. Seaman(Reuters Health) – In general, childhood cancer survivors are just as satisfied with their sex lives as people who didn’t have ca More »
Cellectis has won U.S. regulatory approval to run an early clinical trial using its gene edited cell therapy product UCART123 for blood cancers, boosting the French biotech firm’s ambitions in the hot area of cancer research. More »
European prices for some off-patent cancer drugs have risen by more than 100 percent in the past five years, with two cases of hikes exceeding 1,000 percent, according to data presented at a medical conference on Saturday. More »
Two babies rescued from previously incurable leukemia after receiving infusions of gene-edited immune cells are doing well at home more than a year after initial treatment, scientists said on Wednesday. More »
FILE PHOTO: An ash tray with cigarette butts is pictured in Hinzenbach, Austria, February 5, 2012. REUTERS/Lisi Niesner/File Photo Smoking costs the global economy more than $1 trillion a year, and will kill one third more people by 2030 than it does now, acco... More »
By Andrew M. Seaman(Reuters Health) – The number of older women in the U.S. being screened for breast cancer increased after the Affordable Care Act More »
By Lisa Rapaport(Reuters Health) – Widespread breast cancer screening may catch more small, slow-growing tumors that are unlikely to be fatal without More »
Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments. More »
By Andrew M. Seaman(Reuters Health) – Drugs recently approved around the world to fight cancer increased patients’ overall survival, but benefits va More »
By Lisa Rapaport(Reuters Health) – Women with cancer in one breast may opt to have both breasts removed even though a double mastectomy isn’t always More »
By Randi Belisomo(Reuters Health) – To humanize the intensive care unit and comfort families of the dying, Canadian doctors have found a way to elici More »
By Andrew M. SeamanMelanoma survivors may want to enlist partners to help search their bodies for suspicious looking moles, according to new researc More »
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young a... More »
Herve Brailly, CEO of Innate Pharma, attends the Reuters Biotech summit in Paris June 3, 2009. REUTERS/John Schults France’s Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent f... More »
By Lisa Rapaport(Reuters Health) – – Children who’ve had cancer may be more likely to receive the follow-up care they need in adulthood if their pare More »
By Lisa Rapaport(Reuters Health) – Despite advances that have made treatments safer and more effective, childhood cancer survivors don’t appear to ha More »
By Kathryn Doyle(Reuters Health) – For patients with advanced cancer, palliative care should start early and be an integral part of treatment, not ju More »
Cancer drugmakers are cutting prices to ensure their medicines are used routinely on Britain’s National Health Service, following the overhaul of a cancer drug funding scheme, with Japan’s Eisai the latest to win approval. More »
By Madeline KennedyReuters – The increased risk of stroke that comes with smoking may extend to nonsmokers who live in the same household and breathe More »
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency (EMA) on Frid... More »
Scientists launched a global initiative on Friday to map out and describe every cell in the human body in a vast atlas that could transform researchers’ understanding of human development and disease. More »
By Lisa Rapaport(Reuters Health) – Chemotherapy regimens for breast cancer can vary wildly in price even when they are comparable in their ability to More »
By Andrew M. Seaman(Reuters Health) – People with terminal illnesses may legally end their lives with certain medications in the U.S. state of Washi More »
A trader passes by a screen displaying the tickers symbol for Bristol-Myers Squibb on the floor at the New York Stock Exchange, April 25, 2013. REUTERS/Brendan McDermid New data is likely to prompt doctors to abandon Bristol-Myers Squibb’s immunotherapy Opdivo... More »
By Lisa Rapaport(Reuters Health) – Women with early-stage breast cancer may have fewer treatment complications and lower costs when they don’t get a More »
WASHINGTON The White House announced on Wednesday measures aimed at advancing President Barack Obama’s precision medicine initiative, including plans to speed the development of tests used to identify genetic mutations and guide medical treatment. The U.S. Foo... More »
CHICAGO A new type of cancer drug that takes the brakes off the body’s immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach. Dr. Richard Pazdur, he... More »
CHICAGO A new wave of experimental cancer drugs that directly recruit the immune system’s powerful T cells could begin reaching patients next year, according to companies presenting new data at the annual meeting of the American Society of Clinical Oncology. I... More »
CHICAGO Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient’s tumor rather than the organ in which the cancer was originally detected. T... More »
CAMBRIDGE, England AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines. The initiative, anno... More »
The U.S. Food and Drug Administration on Friday moved to revoke approval of a drug used to treat certain diseases in pigs because it could leave a cancerous residue that may affect human health. The drug, carbadox, is made by Teaneck, New Jersey-based Phibro A... More »
(Reuters Health) – U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a rece... More »
Johnson & Johnson (JNJ.N) was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company’s talc-based Baby Powder and Shower to Shower for several decades. In a v... More »
